AvantGen is a San Diego-based biotechnology company specializing in antibody discovery and optimization for therapeutic, diagnostic, and research applications. Its proprietary yeast display platform, fully human antibody libraries containing more than 100 billion clones, and deep-sequenced antibody database support rapid identification of high-affinity, developable candidates. AvantGen also offers antibody engineering, affinity maturation, humanization, rabbit monoclonal antibody generation, VHH nanobody discovery, and support for challenging targets and advanced modalities.
AvantGen
AvantGen is an innovative biotechnology company focused on antibody discovery and optimization using its proprietary yeast display technology and robust human antibody libraries. Partnering with biopharmaceutical firms, AvantGen accelerates the development of novel therapeutic antibodies, offering deep expertise in engineering high-affinity, developable candidates against challenging biological targets.
The Latest Insights & Innovations from
AvantGen
No items found.
Blog
Years-long Development Cycles Are Making Pharma Companies Rethink Phage Display and Immunization Methods for Antibody Discovery
March 26, 2024
Learn more
No items found.
No items found.